Osegueda-Mayen JR, Sarmiento-Aguilar A

Language: Spanish
References: 25
Page: 167-173
PDF size: 197.91 Kb.

ABSTRACT

Introduction: A premature birth represents a nutritional emergency. An immediately available or standardized parenteral nutrition is an essential tool to offer an adequate nutritional input of macro and micronutrients to this group of patients. In this article we resume and compare the nutritional components of standardized and personalized parenteral nutrition, and we report a clinical case where we successfully used the standardized parenteral nutrition within the first two hours of life.
Case presentation: A 30.5 gestational weeks premature female entered the neonatal intensive care unit. We initiated standardized parenteral nutrition within the first 2 hours of life through an umbilical venous catheter. She had an adequate nutritional evolution until week 42 of corrected age, where she presented weight localized in 10th percentile according to Integrowth-21. The present work aims to review the usefulness of standardized parenteral nutrition in premature newborns. Its arrival in Mexico is recent, the case of a patient in which it was used with positive results is reported.
Conclusions: Every neonatal unit should consider a premature birth as a nutritional emergency, where a prompt start of parenteral nutrition is crucial for maintaining an optimal nutrition and growth. Standardized parenteral nutrition is until now the best way for the premature newborn to receive the required nutritional requirement early after birth.

REFERENCES

1. Morgan C. Early amino acid administration in very preterminfants: Too little, too late or too much, too soon? SeminFetal Neonatal Med. 2013;18(3):160–5. DOI: 10.1016/j.siny.2013.02.002

2. Joosten K, Embleton N, Yan W, Senterre T, Braegger C,Bronsky J, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelineson pediatric parenteral nutrition: Energy. Clin Nutr.2018;37(6):2309–14.

3. Ray S. NICE guideline review: Neonatal parenteral nutrition(NG154). Arch Dis Child Educ Pract Ed. 2021 Oct;106(5):292-295. doi: 10.1136/archdischild-2020-320581

4. Riskin A, Picaud JC, Shamir R, Braegger C, Bronsky J, Cai W,et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatricparenteral nutrition: Standard versus individualized parenteralnutrition. Clin Nutr. 2018;37(6):2409–17.

5. Embleton ND, Van den Akker CHP. Protein intakes tooptimize outcomes for preterm infants. Semin Perinatol.2019;43(7).

6. Van Goudoever JB, Carnielli V, Darmaun D, Sainz de PipaonM, Braegger C, Bronsky J, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Aminoacids. Clin Nutr. 2018;37(6):2315–23.

7. Calkins KL, Puder M, Gura K. The evolving use of intravenouslipid emulsions in the neonatal intensive care unit.Semin Perinatol. 2019;43(7).

8. Lapillonne A, Fidler Mis N, Goulet O, van den Akker CHP,Wu J, Koletzko B, et al. ESPGHAN/ESPEN/ESPR/CSPENguidelines on pediatric parenteral nutrition: Lipids. ClinNutr. 2018;37(6):2324–36.

9. Frazer LC, Martin CR. Parenteral lipid emulsions in thepreterm infant: Current issues and controversies. Arch DisChild Fetal Neonatal Ed. 2021:1–6.

10. Molina-Poveda C. Nutrient requirements. Eleventh E.Aquafeed Formulation. Elsevier Inc.; 2016. 75–216 p. DOI:10.1016/B978-0-323-56711-4.00041-9

11. Mesotten D, Joosten K, van Kempen A, Verbruggen S,Braegger C, Bronsky J, et al. ESPGHAN/ESPEN/ESPR/CSPENguidelines on pediatric parenteral nutrition: Carbohydrates.Clin Nutr. 2018;37(6):2337–43.

12. Marinier E, Liebert F, Guerriero E, Dugelay E, Leuvray M,Martinez-Vinson C, et al. Nutrición parenteral en lactantesy niños. EMC - Pediatría. 2020;55(4):1–20.

13. Karpen HE. Mineral Homeostasis and Effects on BoneMineralization in the Preterm Neonate. Clin Perinatol.2017;45(1):129-141 DOI: 10.1016/j.clp.2017.11.005

14. Jochum F, Moltu SJ, Senterre T, Nomayo A, Goulet O, IacobelliS, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelines onpediatric parenteral nutrition: Fluid and electrolytes. ClinNutr. 2018;37(6):2344–53.

15. Segar JL. A physiological approach to fluid and electrolytemanagement of the preterm infant: Review. J NeonatalPerinatal Med. 2020;13(1):11–9.

16. Mihatsch W, Fewtrell M, Goulet O, Molgaard C, Picaud JC,Senterre T, et al. ESPGHAN/ESPEN/ESPR/CSPEN guidelineson pediatric parenteral nutrition: Calcium, phosphorus andmagnesium. Clin Nutr. 2018;37(6):2360–5.

17. Stephens BE, Walden R V., Gargus RA, Tucker R, McKinleyL, Mance M, et al. First-week protein and energy intakesare associated with 18-month developmental outcomesin extremely low birth weight infants. Pediatrics.2009;123(5):1337–43.

18. Stephens BE, Vohr BR. Neurodevelopmental Outcomeof the Premature Infant. Pediatr Clin North Am.2009;56(3):631–46. DOI: 10.1016/j.pcl.2009.03.005

19. Belfort MB, Ehrenkranz RA. Neurodevelopmental outcomesand nutritional strategies in very low birth weightinfants. Semin Fetal Neonatal Med. 2017;22(1):42–8. DOI:10.1016/j.siny.2016.09.001

20. Bolisetty S, Osborn D, Schindler T, Sinn J, Deshpande G,Wong CS, et al. Standardised neonatal parenteral nutritionformulations-Australasian neonatal parenteral nutritionconsensus update 2017. BMC Pediatr. 2020;20(1):1–11.

21. Calkins KL, Robinson DT. Intravenous lipid emulsions in theNICU. Neoreviews. 2020;21(2):e109–19.

22. Hewawasam E, Collins CT, Muhlhausler BS, Yelland LN,Smithers LG, Colombo J, et al. DHA supplementation ininfants born preterm and the effect on attention at 18months’ corrected age: Follow-up of a subset of the N3ROrandomised controlled trial. Br J Nutr. 2021;125(4):420–31.

23. Collins CT, Gibson RA, Makrides M, McPhee AJ, Sullivan TR,Davis PG, et al. The N3RO trial: A randomised controlledtrial of docosahexaenoic acid to reduce bronchopulmonarydysplasia in preterm infants <29 weeks’ gestation. BMCPediatr. 2016;16(1):1–9. DOI: 10.1186/s12887-016-0611-0

24. Kapoor V, Malviya MN, Soll R. Lipid emulsions for parenterallyfed preterm infants. Cochrane database Syst Rev.2019;6(6):CD013163.

25. Cleminson J, McGuire W, Embleton N. Commentary on“Lipid Emulsions for Parenterally Fed Preterm Infants.”Neonatology. 2021;118(1):1–4.